<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36813431</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>04</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-1942</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Gastroenterology clinics of North America</Title><ISOAbbreviation>Gastroenterol Clin North Am</ISOAbbreviation></Journal><ArticleTitle>Diarrhea and Coronavirus Disease 2019 Infection.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>75</EndPage><MedlinePgn>59-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gtc.2022.11.001</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0889-8553(22)00089-9</ELocationID><Abstract><AbstractText>The global coronavirus disease-2019 (COVID-19) pandemic has caused significant morbidity and mortality, thoroughly affected daily living, and caused severe economic disruption throughout the world. Pulmonary symptoms predominate and account for most of the associated morbidity and mortality. However, extrapulmonary manifestations are common in COVID-19 infections, including gastrointestinal (GI) symptoms, such as diarrhea. Diarrhea affects approximately 10% to 20% of COVID-19 patients. Diarrhea can occasionally be the presenting and only COVID-19 symptom. Diarrhea in COVID-19 subjects is usually acute but is occasionally chronic. It is typically mild-to-moderate and nonbloody. It is usually much less clinically important than pulmonary or potential thrombotic disorders. Occasionally the diarrhea can be profuse and life-threatening. The entry receptor for COVID-19, angiotensin converting enzyme-2, is found throughout the GI tract, especially in the stomach and small intestine, which provides a pathophysiologic basis for local GI infection. COVID-19 virus has been documented in feces and in GI mucosa. Treatment of COVID-19 infection, especially antibiotic therapy, is a common culprit of the diarrhea, but secondary infections including bacteria, especially Clostridioides difficile, are sometimes implicated. Workup for diarrhea in hospitalized patients usually includes routine chemistries; basic metabolic panel; and a complete hemogram; sometimes stool studies, possibly including calprotectin or lactoferrin; and occasionally abdominal CT scan or colonoscopy. Treatment for the diarrhea is intravenous fluid infusion and electrolyte supplementation as necessary, and symptomatic antidiarrheal therapy, including Loperamide, kaolin-pectin, or possible alternatives. Superinfection with C difficile should be treated expeditiously. Diarrhea is prominent in post-COVID-19 (long COVID-19), and is occasionally noted after COVID-19 vaccination. The spectrum of diarrhea in COVID-19 patients is presently reviewed including the pathophysiology, clinical presentation, evaluation, and treatment.</AbstractText><CopyrightInformation>Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Friedel</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Division of Therapeutic Endoscopy, Division of Gastroenterology, Department of Medicine, New York University Hospital, 259 First Street, Mineola 11501, NY, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cappell</LastName><ForeName>Mitchell S</ForeName><Initials>MS</Initials><AffiliationInfo><Affiliation>Department of Medicine, Gastroenterology Service, Aleda E. Lutz Veterans Administration Hospital at Saginaw, Building 1, Room 3212, 1500 Weiss Street, Saginaw, MI 48602, USA. Electronic address: mitchell.cappell@va.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>11</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Gastroenterol Clin North Am</MedlineTA><NlmUniqueID>8706257</NlmUniqueID><ISSNLinking>0889-8553</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003967" MajorTopicYN="N">Diarrhea</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE-2 (angiotensin converting enzyme-2)</Keyword><Keyword MajorTopicYN="N">C difficile</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Colonoscopy</Keyword><Keyword MajorTopicYN="N">Diarrhea</Keyword><Keyword MajorTopicYN="N">Gastrointestinal symptoms</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Pandemic</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2 (severe acute respiratory syndrome coronavirus-2)</Keyword><Keyword MajorTopicYN="N">Stool studies</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>22</Day><Hour>20</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>2</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>11</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36813431</ArticleId><ArticleId IdType="pmc">PMC9659511</ArticleId><ArticleId IdType="doi">10.1016/j.gtc.2022.11.001</ArticleId><ArticleId IdType="pii">S0889-8553(22)00089-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 Cumulative Infection Collaborators Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis. Lancet. 2022;399(10344):2351.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8993157</ArticleId><ArticleId IdType="pubmed">35405084</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta A., Madhavan M.V., Sehgal K., et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032.</Citation><ArticleIdList><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J., Garrett S., Sun J. Gastrointestinal symptoms, pathophysiology and treatment in Covid-19. Genes Dis. 2021;8(4):385&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836435</ArticleId><ArticleId IdType="pubmed">33521210</ArticleId></ArticleIdList></Reference><Reference><Citation>Cha M.H., Regueiro M., Sandhu D.S. Gastrointestinal and hepatic manifestations of Covid-19: a comprehensive review. World J Gastroenterol. 2020;26(19):2323&#x2013;2332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243653</ArticleId><ArticleId IdType="pubmed">32476796</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappell M.S. Moderately severe diarrhea and impaired renal function with COVID-19 infection. Am J Gastroenterol. 2020;115(6):947&#x2013;948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7273947</ArticleId><ArticleId IdType="pubmed">32453058</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Mu M., Yang P., et al. Clinical characteristics of Covid&#x2013;19 patients with digestive symptoms in Hubei, China: a descriptive cross&#x2013;sectional, multicenter study. Am J Gastroenterol. 2020;115(5):766&#x2013;773.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172492</ArticleId><ArticleId IdType="pubmed">32287140</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Chen L., Deng Q., et al. The presence of SARS-Cov-2 RNA in the feces of Covid&#x2013;19 patients. J&#xa0;Med Virol. 2020;90(7):833&#x2013;870.</Citation><ArticleIdList><ArticleId IdType="pubmed">32243607</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramachandran P., Onukogu I., Ghanta S., et al. Gastrointestinal symptoms and outcomes in hospitalized coronavirus disease 2019 patients. Dig Dis. 2020;38:373&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445385</ArticleId><ArticleId IdType="pubmed">32599601</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho A., Alqusairi R., Adams A., et al. SARS-CoV-2 gastrointestinal infection causing hemorrhagic colitis: Implications for detection and transmission of COVID-19 disease. Am J Gastroenterol. 2020;115:942&#x2013;946.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172485</ArticleId><ArticleId IdType="pubmed">32496741</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S.K., Lee C.W., Park D.I., et al. Detection of SARS-CoV-2 in fecal samples from patients with asymptomatic and mild COVID&#x2013;19 in Korea. Clin Gastroenterol Hepatol. 2021;19(7):1387&#x2013;1394.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286243</ArticleId><ArticleId IdType="pubmed">32534042</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D.L., Baluja M.Q., Greaham D.W., et al. Shedding of SARS-CoV-2 in feces and urine and its potential role in person&#x2013;to&#x2013;person transmission and the environment of COVID 19. Sci Tot Environ. 2020;749:141364.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836549</ArticleId><ArticleId IdType="pubmed">32836117</ArticleId></ArticleIdList></Reference><Reference><Citation>Han C., Duan C., Zhang S., et al. Digestive symptoms in COVID-19 patients with mild disease severity: Clinical presentation, stool viral RNA testing, and outcomes. Am J Gastroenterol. 2020;115:916&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7172493</ArticleId><ArticleId IdType="pubmed">32301761</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Rong L., Nian W., et al. Review article: Gastrointestinal features and COVID-19 and the possibility of faecal transmission. Aliment Pharmacol. 2020;51(9):843&#x2013;851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7161803</ArticleId><ArticleId IdType="pubmed">32222988</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoury N.C., Russo T.J. A&#xa0;case of gastrointestinal-predominant Covid&#x2013;19 demonstrates value of stool PCR test. J&#xa0;Med Virol. 2021;93(2):662&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461382</ArticleId><ArticleId IdType="pubmed">32816305</ArticleId></ArticleIdList></Reference><Reference><Citation>Galanopoulos M., Gkeros F., Doukatas A., et al. COVID&#x2013;19 pandemic: Pathophysiology and manifestations from the gastrointestinal tract. World J Gastroenterol. 2020;26(31):4579&#x2013;4588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7445869</ArticleId><ArticleId IdType="pubmed">32884218</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID&#x2013;19. Gut. 2021;70(4):698&#x2013;706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Parel S., Parikh C., Verma D., et al. Bowel ischemia in COVID&#x2013;19: a systematic review. Int J Clin Pract. 2021;75(12):e14930.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646310</ArticleId><ArticleId IdType="pubmed">34605117</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva F.A.F.D., Brito B.B., Santos M.L.C., et al. COVID-19 gastrointestinal manifestations: a systematic review. Rev Soc Bras Trop Rev. 2020;25(53):e20200714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7723378</ArticleId><ArticleId IdType="pubmed">33263693</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S., Samanta J., Suri V., et al. Presence of diarrhea associated with better outcomes in patients with COVID-19 - A prospective evaluation. Indian J Med Microbiol. 2022;40(3):404&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9271117</ArticleId><ArticleId IdType="pubmed">35483999</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hung I.F.N., Chan P.P.Y., et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: Systematic review and meta-analysis. Gastroenterology. 2020;159(1):81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Megyeri K., Dernovics &#xc1;., Al-Luhaibi Z.I.I., et al. COVID-19-associated diarrhea. World J Gastroenterol. 2021;27(23):3208&#x2013;3222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8218355</ArticleId><ArticleId IdType="pubmed">34163106</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan W.J., Ni Z.Y., Hu Y., et al. China Medical Treatment Expert Group for Covid-19. Clinical characteristics of coronavirus disease 2019 in China. NEJM. 2020;382:1708&#x2013;1720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao F., Tang M., Zheng X., et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831&#x2013;1833.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung W.K., To K.F., Chan P.K., et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125:1011&#x2013;1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7126982</ArticleId><ArticleId IdType="pubmed">14517783</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395:507&#x2013;513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7135076</ArticleId><ArticleId IdType="pubmed">32007143</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Maqbali M., Al Badi K., Sinani M Al, et al. Clinical features of COVID-19 patients in the first year of pandemic: A systematic review and meta-analysis. Biol Res Nurs. 2022;24(2):172&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8968436</ArticleId><ArticleId IdType="pubmed">34866409</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico F., Baumgart D.C., Danese S., et al. Diarrhea during COVID-19 infection: Pathogenesis, epidemiology, prevention, and management. Clin Gastroenterol Hepatol. 2020;18(8):1663&#x2013;1672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7141637</ArticleId><ArticleId IdType="pubmed">32278065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shehab M., Alrashed F., Shuaibi S., et al. Gastroenterological and hepatic manifestations of patients with COVID-19, prevalence, mortality by country, and intensive care admission rate: systematic review and meta-analysis. BMJ Open Gastroenterol. 2021;8(1):e000571.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934201</ArticleId><ArticleId IdType="pubmed">33664052</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshazli R.M., Kline A., Elgaml A., et al. Gastroenterology manifestations and COVID-19 outcomes: a meta-analysis of 25,252 cohorts among the first and second waves. J&#xa0;Med Virol. 2021;93(5):2740&#x2013;2768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014082</ArticleId><ArticleId IdType="pubmed">33527440</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A., Rinaldi E., Zusi C., et al. Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis. Pediatr Res. 2021;89(4):733&#x2013;737.</Citation><ArticleIdList><ArticleId IdType="pubmed">32555539</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel N.A. Pediatric COVID-19: Systematic review of the literature. Am J Otolaryngol. 2020;41(5):102573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833675</ArticleId><ArticleId IdType="pubmed">32531620</ArticleId></ArticleIdList></Reference><Reference><Citation>Mansourian M., Ghandi Y., Habibi D., et al. COVID-19 infection in children: a systematic review and meta-analysis of clinical features and laboratory findings. Arch Pediatr. 2021;28(3):242&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794595</ArticleId><ArticleId IdType="pubmed">33483192</ArticleId></ArticleIdList></Reference><Reference><Citation>Radia T., Williams N., Agrawal P., et al. Multi-system inflammatory syndrome in children &amp; adolescents (MIS-C): A systematic review of clinical features and presentation. Paediatr Respir Rev. 2021;38:51&#x2013;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417920</ArticleId><ArticleId IdType="pubmed">32891582</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Yuan X. Digestive system symptoms and function in children with COVID-19: A meta-analysis. Medicine (Baltimore) 2021;19;100(11):e24897.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7982203</ArticleId><ArticleId IdType="pubmed">33725961</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin X., Lian J.S., Hu J.H., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69:1002&#x2013;1009.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7133387</ArticleId><ArticleId IdType="pubmed">32213556</ArticleId></ArticleIdList></Reference><Reference><Citation>Tariverdi M., Farahbakhsh N., Gouklani H., et al. Dysentery as the only presentation of COVID-19 in a child: a case report. J&#xa0;Med Case Rep. 2021;15(1):65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7870123</ArticleId><ArticleId IdType="pubmed">33557906</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslennikov R., Pouluektova E., Ivashkin V., et al. Diarrhoea in adults with coronavirus-beyond incidence and mortality: a systematic review and meta-analysis. Infect Dis (Lond) 2021;53(5):348&#x2013;360.</Citation><ArticleIdList><ArticleId IdType="pubmed">33583306</ArticleId></ArticleIdList></Reference><Reference><Citation>Aroniadis O.C., Wang X., Gong T., et al. Factors associated with the development of gastrointestinal symptoms in patients hospitalized with Covid-19. Dig Dis Sci. 2022;67(8):3860&#x2013;3871.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575674</ArticleId><ArticleId IdType="pubmed">34751837</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers H.K., Choi W.W., Gowda N., et al. Frequency and outcomes of gastrointestinal symptoms in patients with Corona Virus Disease-19. Indian J Gastroenterol. 2021;40(5):502&#x2013;511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8475883</ArticleId><ArticleId IdType="pubmed">34569014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng W., Qi K., Ye M., et al. Gastrointestinal symptoms are associated with severity of coronavirus disease 2019: A systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022;34(2):168&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">33470700</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi Y., Wagatsuma K., Nojima M., et al. The characteristics of gastrointestinal symptoms in patients with severe COVID-19: A systematic review and meta-analysis. J&#xa0;Gastroenterol. 2021;56(5):409&#x2013;420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7987120</ArticleId><ArticleId IdType="pubmed">33759041</ArticleId></ArticleIdList></Reference><Reference><Citation>Schettino M., Pellegrini L., Picascia D., et al. Clinical characteristics of COVID-19 patients with gastrointestinal symptoms in Northern Italy: a single-center cohort study. Am J Gastroenterol. 2021;116(2):306&#x2013;310.</Citation><ArticleIdList><ArticleId IdType="pubmed">33009054</ArticleId></ArticleIdList></Reference><Reference><Citation>Fallouh N.A., Naik K.H., Udochi C.O., et al. Better clinical outcomes in hospitalized COVID-19&#xa0;minority patients with accompanying gastrointestinal symptoms. J&#xa0;Natl Med Assoc. 2022;113(6):626&#x2013;635.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8226059</ArticleId><ArticleId IdType="pubmed">34176663</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh B., Ryan H., Kredo T., et al. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Cochrane Database Syst Rev. 2021;2(2):CD013587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8094389</ArticleId><ArticleId IdType="pubmed">33624299</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W., Chen C., Tang J., et al. Efficacy and safety of three new oral antiviral treatment (molnupiravir, fluvoxamine and Paxlovid) for COVID-19: A meta-analysis. Ann Med. 2022;54(1):516&#x2013;523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8820829</ArticleId><ArticleId IdType="pubmed">35118917</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu M.N., Bhardwaj M., Sah S.P., et al. Safety profile of COVID-19 drugs in a real clinical setting. Eur J Clin Pharmacol. 2022;78(5):733&#x2013;753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8794611</ArticleId><ArticleId IdType="pubmed">35088108</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuftinec G., Elmunzer B.J., Amin S., et al. The role of endoscopy and findings in COVID-19 patients: An early North American Cohort. BMC Gastroenterol. 2021;21(1):205.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8102844</ArticleId><ArticleId IdType="pubmed">33962582</ArticleId></ArticleIdList></Reference><Reference><Citation>Massironi S., Vigan&#xf2; C., Dioscoridi L., et al. Endoscopic findings in patients infected with 2019 novel coronavirus in Lombardy, Italy. Clin Gastroenterol Hepatol. 2020;18(10):2375&#x2013;2377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260560</ArticleId><ArticleId IdType="pubmed">32480008</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanella G., Capurso G., Burti C., et al. Gastrointestinal mucosal damage in patients with COVID-19 undergoing endoscopy: an international multicentre study. BMJ Open Gastroenterol. 2021;8(1):e000578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7907837</ArticleId><ArticleId IdType="pubmed">33627313</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie X.P., Sheng L.P., Han C.Q., et al. Features of capsule endoscopy in COVID-19 patients with a six-month follow-up: A prospective observational study. J&#xa0;Med Virol. 2022;94(1):246&#x2013;252.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8662114</ArticleId><ArticleId IdType="pubmed">34460118</ArticleId></ArticleIdList></Reference><Reference><Citation>Boraschi P., Giugliano L., Mercogliano G., et al. Abdominal and gastrointestinal manifestations in COVID-19 patients: Is imaging useful? World J Gastroenterol. 2021;14(27):4143&#x2013;4159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8311532</ArticleId><ArticleId IdType="pubmed">34326615</ArticleId></ArticleIdList></Reference><Reference><Citation>Caruso D., Zerunian M., Pucciarelli F., et al. Imaging of abdominal complications of COVID-19 infection. BJR Open. 2021;2(1):20200052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8320136</ArticleId><ArticleId IdType="pubmed">34381937</ArticleId></ArticleIdList></Reference><Reference><Citation>Gubatan J., Zikos T., Spear Bishop E., et al. Gastrointestinal symptoms and health care utilization have increased among patients with functional gastrointestinal and motility disorders during the COVID-19 pandemic. Neurogastroenterol Motil. 2022;34(4):e14243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8420203</ArticleId><ArticleId IdType="pubmed">34378840</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguila E., Cua I. Dumagpi J When do you say it's SARS-CoV-2-associated diarrhea? J&#xa0;Gastroenterol Hepatol. 2020;35(9):1652&#x2013;1653.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307072</ArticleId><ArticleId IdType="pubmed">32525578</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow C.S., Hasan S.S. The use of antimotility drugs in COVID-19 associated diarrhea. J&#xa0;Infect. 2021;82(2):e19.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7501078</ArticleId><ArticleId IdType="pubmed">32956731</ArticleId></ArticleIdList></Reference><Reference><Citation>Shirohata A., Ariyoshi R., Fujigaki S., et al. A&#xa0;case of COVID-19 diarrhea relieved by bile acid sequestrant administration. Clin J Gastroenterol. 2022;15(2):393&#x2013;400.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8815721</ArticleId><ArticleId IdType="pubmed">35122223</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu K., Hirata H., Kabata D., et al. Ivermectin administration is associated with lower gastrointestinal complications and greater ventilator-free days in ventilated patients with COVID-19: A propensity score analysis. J&#xa0;Infect Chemother. 2022;28(4):548&#x2013;553.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8718885</ArticleId><ArticleId IdType="pubmed">35016823</ArticleId></ArticleIdList></Reference><Reference><Citation>Uyaro&#x11f;lu O.A., G&#xfc;ven G.S., G&#xfc;ll&#xfc; &#x130;. Can Levamisole be used in the treatment of COVID-19 patients presenting with diarrhea? J&#xa0;Infect Dev Ctries. 2020;14(8):844&#x2013;846.</Citation><ArticleIdList><ArticleId IdType="pubmed">32903227</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul A.K., Jahan R., Bondhon T.A., et al. Potential role of flavonoids against SARS-CoV-2-induced diarrhea. Trop Biomed. 2021;38(3):360&#x2013;365.</Citation><ArticleIdList><ArticleId IdType="pubmed">34508344</ArticleId></ArticleIdList></Reference><Reference><Citation>Poeta M., Cioffi V., Buccigrossi V., et al. Diosmectite inhibits the interaction between SARS-CoV-2 and human enterocytes by trapping viral particles, thereby preventing NF-kappaB activation and CXCL10 secretion. Sci Rep. 2021;11(1):21725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8571314</ArticleId><ArticleId IdType="pubmed">34741071</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi S., Wang F., Li J., et al. The effect of Chinese herbal medicine on digestive system and liver functions should not be neglected in COVID-19: An updated systematic review and meta-analysis. IUBMB Life. 2021;73(5):739&#x2013;760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250823</ArticleId><ArticleId IdType="pubmed">33725395</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou K.L., Dong S., Fu G.B., et al. Tuina (massage) therapy for diarrhea in COVID-19: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2020;99(28):e21293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7360276</ArticleId><ArticleId IdType="pubmed">32664185</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H., Wang Y., Lu C., et al. The efficacy of probiotics in patients with severe COVID-19. Ann Palliat Med. 2021;10(12):12374&#x2013;12380.</Citation><ArticleIdList><ArticleId IdType="pubmed">35016484</ArticleId></ArticleIdList></Reference><Reference><Citation>Mak J.W.Y., Chan F.K.L., Ng S.C. Probiotics and COVID-19: One size does not fit all. Lancet Gastroenterol Hepatol. 2020;5(7):644&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7182525</ArticleId><ArticleId IdType="pubmed">32339473</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikucka A., Deptu&#x142;a A., Bogiel T., et al. Bacteraemia caused by probiotic strains of Lacticaseibacillus rhamnosus: Case studies highlighting the need for careful thought before using microbes for health benefits. Pathogens. 2022;11(9):977.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9504050</ArticleId><ArticleId IdType="pubmed">36145409</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Q.Y., Chen Y.X., Fang J.Y. 2019 Novel coronavirus infection and gastrointestinal tract. J&#xa0;Dig Dis. 2020;21(3):125&#x2013;126.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7162053</ArticleId><ArticleId IdType="pubmed">32096611</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceccarelli G., Borrazzo C., Pinacchio C., et al. Oral bacteriotherapy in patients with COVID-19: A retrospective cohort study. Front Nutr. 2021;7:613928.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7829198</ArticleId><ArticleId IdType="pubmed">33505983</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Vidal C., Sanjuan G., Moreno-Garc&#xed;a E., et al. Incidence of co-infections and superinfections in hospitalized patients with Covid-19: A retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836762</ArticleId><ArticleId IdType="pubmed">32745596</ArticleId></ArticleIdList></Reference><Reference><Citation>Laszkowska M., Kim J., Faye A.S., et al. Prevalence of Clostridioides difficile and other gastrointestinal pathogens in patients with COVID-19. Dig Dis Sci. 2021;66(12):4398&#x2013;4405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7819769</ArticleId><ArticleId IdType="pubmed">33479861</ArticleId></ArticleIdList></Reference><Reference><Citation>Carll W.C., Rady M.Y., Salomao M.A., et al. Cytomegalovirus haemorrhagic enterocolitis associated with severe infection with COVID-19. BMJ Open Gastroenterol. 2021;8(1):e000556.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7804824</ArticleId><ArticleId IdType="pubmed">33436481</ArticleId></ArticleIdList></Reference><Reference><Citation>Osuna-Padilla I., Rodr&#xed;guez-Moguel N.C., Aguilar-Vargas A., et al. Safety and tolerance of enteral nutrition in COVID-19 critically ill patients, a retrospective study. Clin Nutr ESPEN. 2021;43:495&#x2013;500.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901378</ArticleId><ArticleId IdType="pubmed">34024561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmoud S., El-Kalliny M., Kotby A., et al. Treatment of MIS-C in children and adolescents. Curr Pediatr Rep. 2022;10(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8741532</ArticleId><ArticleId IdType="pubmed">35036079</ArticleId></ArticleIdList></Reference><Reference><Citation>Azimirad M., Noori M., Raeisi H., et al. How does COVID-19 pandemic impact on Incidence of Clostridioides difficile infection and exacerbation of Its gastrointestinal symptoms? Front Med (Lausanne) 2021;8:775063.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8710593</ArticleId><ArticleId IdType="pubmed">34966759</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawes A.M., Desai A., Patel P.K. Did Clostridioides difficile testing and infection rates change during the COVID-19 pandemic? Anaerobe. 2021;70:102384.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8141342</ArticleId><ArticleId IdType="pubmed">34029702</ArticleId></ArticleIdList></Reference><Reference><Citation>Yadlapati S., Jarrett S.A., Lo K.B., et al. Examining the rate of Clostridioides (formerly Clostridium) difficile infection pre- and post-COVID-19 pandemic: An institutional review. Cerus. 2021;13(12):e20397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8754356</ArticleId><ArticleId IdType="pubmed">35036227</ArticleId></ArticleIdList></Reference><Reference><Citation>Granata G., Petrosillo N., Al Moghazi S., et al. The burden of Clostridioides difficile infection in COVID-19 patients: A systematic review and meta-analysis. Anaerobe. 2022;74:102484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8616765</ArticleId><ArticleId IdType="pubmed">34843959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sehgal K., Fadel H.J., Tande A.J., et al. Outcomes in patients with SARS-CoV-2 and Clostridioides difficile coinfection. Infect Drug Resist. 2021;14:1645&#x2013;1648.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8089469</ArticleId><ArticleId IdType="pubmed">33953575</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslennikov R., Ivashkin V., Ufimtseva A., et al. Clostridioides difficile co-infection in patients with COVID-19. Future Microbiol. 2022;17:653&#x2013;663.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9020461</ArticleId><ArticleId IdType="pubmed">35440149</ArticleId></ArticleIdList></Reference><Reference><Citation>Maslennikov R., Svistunov A., Ivashkin V., et al. Early viral versus late antibiotic-associated diarrhea in novel coronavirus infection. Medicine (Baltimore) 2021;100(41):e27528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8519250</ArticleId><ArticleId IdType="pubmed">34731146</ArticleId></ArticleIdList></Reference><Reference><Citation>Khanna S., Tande A., Rubin D.T., et al. Fecal microbiota transplantation for recurrent C difficile infection during the COVID-19 pandemic: Experience and recommendations. Mayo Clin Proc. 2021;96(6):1418&#x2013;1425.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169126</ArticleId><ArticleId IdType="pubmed">34088413</ArticleId></ArticleIdList></Reference><Reference><Citation>Elbadry M., Medhat M.A., Zaky S., et al. Ulcerative colitis as a possible sequela of COVID-19 infection: The endless story. Arab J Gastroenterol. 2022;23(2):134&#x2013;137.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828424</ArticleId><ArticleId IdType="pubmed">35473685</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbassi B., Deb A., Costilla V., et al. Subacute enteritis two months after COVID-19 pneumonia with mucosal bleeding, perforation, and internal fistulas. Am Surg. 2021;1 31348211023461.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10251175</ArticleId><ArticleId IdType="pubmed">34060929</ArticleId></ArticleIdList></Reference><Reference><Citation>Parigi T.L., Bonifacio C., Danese S. Is it Crohn&#x2019;s disease? Gastroenterology. 2020;159(4):1244&#x2013;1246.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194052</ArticleId><ArticleId IdType="pubmed">32371110</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A.K., Jena A., Kumar -M.P., et al. Clinical presentation of COVID-19 in patients with inflammatory bowel disease: A systematic review and meta-analysis. Intest Res. 2022;20(1):134&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831773</ArticleId><ArticleId IdType="pubmed">33440918</ArticleId></ArticleIdList></Reference><Reference><Citation>Taxonera C., Sagastagoitia I., Alba C., et al. 2019 novel coronavirus disease (COVID-19) in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2020;52(2):276&#x2013;283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267496</ArticleId><ArticleId IdType="pubmed">32359205</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Ani A.H., Prentice R.E., Rentsch C.A., et al. Review article: Prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther. 2020;52(1):54&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267115</ArticleId><ArticleId IdType="pubmed">32348598</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro F., Rahier J.F., Abreu C., et al. Inflammatory bowel disease management during the COVID-19 outbreak: The ten do's and don'ts from the ECCO-COVID Taskforce. J&#xa0;Crohn Colitis. 2020;14(14 Suppl 3):S798&#x2013;S806.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454472</ArticleId><ArticleId IdType="pubmed">32722754</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalili H., Zheng T., S&#xf6;derling J., et al. Association between collagenous and lymphocytic colitis and risk of severe coronavirus disease 2019. Gastroenterology. 2021;160(7):2585&#x2013;2587.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7892313</ArticleId><ArticleId IdType="pubmed">33610527</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar I.O., Langman G., Quraishi M.N., et al. SARS-CoV-2-triggered lymphocytic colitis. BMJ Case Rep. 2021;14(8):e243003.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8386217</ArticleId><ArticleId IdType="pubmed">34429288</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan G.T. COVID-19-induced collagenous colitis. Gastro Hep Adv. 2022;1(6):976.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9343740</ArticleId><ArticleId IdType="pubmed">35938057</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin R., Thomas A.S., Khurana S., et al. Management of immune-related colitis during the COVID-19 pandemic. Inflamm Bowel Dis. 2020;26(10):e110&#x2013;e111.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7454566</ArticleId><ArticleId IdType="pubmed">32812047</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata E., Monsalve D.M., Acosta-Ampudia Y., et al. Post-COVID study group Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20(11):102947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Ailshire J.A., Crimmins E.M. Long COVID and symptom trajectory in a representative sample of Americans in the first year of the pandemic. Sci Rep. 2022;12(1):11647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9264749</ArticleId><ArticleId IdType="pubmed">35804058</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Tariq R., Jena A., et al. Gastrointestinal manifestations of long COVID: a systematic review and meta-analysis. Therap Adv Gastroenterol. 2022;15 17562848221118403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J., Li Y., Li J., et al. Gastrointestinal sequelae 90&#xa0;days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021;6(5):344&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Noviello D., Costantino A., Muscatello A., et al. Functional gastrointestinal and somatoform symptoms five months after SARS-CoV-2 infection: A controlled cohort study. Neurogastroenterol Motil. 2022;34(2):e14187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209890</ArticleId><ArticleId IdType="pubmed">34060710</ArticleId></ArticleIdList></Reference><Reference><Citation>Augustin M., Schommers P., Stecher M., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129613</ArticleId><ArticleId IdType="pubmed">34027514</ArticleId></ArticleIdList></Reference><Reference><Citation>Settanni C.R., Ianiro G., Ponziani F.R., et al. COVID-19 as a trigger of irritable bowel syndrome: a review of potential mechanism. World J Gastroenterol. 2021;27(43):7433&#x2013;7445.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8613742</ArticleId><ArticleId IdType="pubmed">34887641</ArticleId></ArticleIdList></Reference><Reference><Citation>Borch L., Holm M., Knudsen M., et al. Long COVID symptoms and duration in SARS-CoV-2 positive children - a nationwide cohort study. Eur J Pediatr. 2022;181(4):1597&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8742700</ArticleId><ArticleId IdType="pubmed">35000003</ArticleId></ArticleIdList></Reference><Reference><Citation>Akaishi T., Takahashi T., Sato S. Prolonged diarrhea following COVID-19 vaccination: A case report and literature review. Tohoku J Exp Med. 2022;257(3):251&#x2013;259.</Citation><ArticleIdList><ArticleId IdType="pubmed">35644543</ArticleId></ArticleIdList></Reference><Reference><Citation>https://www.cdc.gov/vaccines/covid-19/info-by-product/pfizer/reactogenicity.html. (Accessed 4 October 2022).</Citation></Reference><Reference><Citation>Pormohammad A., Zarei M., Ghorbani S., et al. Efficacy and safety of COVID-19 vaccines: A systematic review and meta-analysis of randomized clinical trials. Vaccines (Basel) 2021;9(5):467.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8148145</ArticleId><ArticleId IdType="pubmed">34066475</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune A., Iyengar K.P., Goddard C., et al. Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V) BMJ Case Rep. 2021;14(7):e243888.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8323360</ArticleId><ArticleId IdType="pubmed">34326117</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>